Samjin Pharmaceuticals Co., Ltd. (KRX:005500)

South Korea · Delayed Price · Currency is KRW

18,260

+150 (0.83%)

At close: Mar 13, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2022	FY 2021	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005
Period Ending	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '12 Dec 31, 2012	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009	Dec '08 Dec 31, 2008	Dec '07 Dec 31, 2007	Dec '06 Dec 31, 2006	Dec '05 Dec 31, 2005
Manufacture of Medicine	274.03B	250.07B	185.70B	201.76B	200.41B
Manufacture of Medicine Growth	9.58%	34.66%	-7.96%	0.67%	21.18%
Total	274.03B	250.07B	185.70B	201.76B	200.41B
Total Growth	9.58%	34.66%	-7.96%	0.67%	21.18%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2022	FY 2021	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005
Period Ending	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '12 Dec 31, 2012	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009	Dec '08 Dec 31, 2008	Dec '07 Dec 31, 2007	Dec '06 Dec 31, 2006	Dec '05 Dec 31, 2005
South Korea	268.86B	246.49B	185.70B	201.76B	-
South Korea Growth	9.08%	32.74%	-7.96%	-	-
Overseas	5.17B	3.58B	-	-	-
Overseas Growth	44.47%	-	-	-	-
Total	274.03B	250.07B	185.70B	201.76B	-
Total Growth	9.58%	34.66%	-7.96%	-	-

Source: S&P Global Market Intelligence.